RxSight share price logo

RxSight

NASDAQ: RXST

$4.88

+0.19

(+4.05%)

as on

RxSight Stock Performance

as on October 21, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $4.66
    $4.92
    downward going graph

    4.51%

    Downside

    0.82%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $4.40
    $13.22
    downward going graph

    9.84%

    Downside

    170.90%

    Upside

    downward going graph

RxSight share price movements today

Previous Close
$4.69
Open
$4.74
Volume
636.4K
Market Cap
$187.6M
Day's Low - High
$4.66 - $4.92
52 Week Low - High
$4.40 - $13.22

RxSight Historical Returns

1 Month Return
-9.81 %
3 Month Return
-16.4 %
1 Year Return
-45.02 %
3 Year Return
-80.97 %
5 Year Return
-60.19 %

RxSight Stock Fundamentals & Key Indicators

Check RxSight market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$187.6M

EPS (TTM)

-1.13

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-3.99

Industry PE ratio

-4.98

PEG Ratio

0.12

EBITDA

-43.3M

Revenue (TTM)

127.6M

Profit Margin

77.50%

Return On Equity TTM

-17.35%

RxSight vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of RxSight with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
RxSight image
RxSight
Neutral$187.6M-60.19%-3.9977.50%0.00%
Medtronic image
Medtronic
Buy$121.2B-23.83%23.1766.69%3.02%
Edwards Lifesciences image
Edwards Lifesciences
Buy$49.9B-24.55%49.7777.98%0.00%
Stryker image
Stryker
StrongBuy$113.0B8.83%30.2865.17%1.19%
Abbott Laboratories image
Abbott Laboratories
StrongBuy$181.5B-15.61%33.7256.80%2.40%
See all

Stock Returns calculator for RxSight Stock including INR - Dollar returns

The RxSight stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

RxSight investment value today

Current value as on today

₹61,803

Returns

-₹38,197

(-38.2%)

Returns from RxSight Stock

-₹42,790 (-42.79%)

Dollar Impact

₹4,593 (+4.59%)

Analyst Recommendation on RxSight Stock

Based on 5 analysts

HOLD

0.00%

Buy

80.00%

Hold

20.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'HOLD' rating for RxSight. Average target price of $7.57

RxSight Share Price Target

Get share price movements and forecasts by analysts on RxSight.

What analysts predicted

35.54%UPSIDE

Target Price

$7.57

Current Price

$4.88

Analyzed by

5 Analysts

High

$10

Target

$7.57

Low

$6

RxSight target price $7.57, a slight upside of 35.54% compared to current price of $4.88. According to 5 analysts rating.

Indian Investors' Interest in RxSight Stock

Search interest for RxSight Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

RxSight Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
29
34
45
40
37
33
30
32
30
33
Gross Profit
20
24
25
28
28
25
24
25
23
25
Operating Income
-10
-8
-9
-8
-10
-14
-12
-11
-17
-13
EBITDA
-7
-5
-5
-5
-7
-10
-8
-8
-15
-11
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
1
0
1
0
0
0
0
0
0
0
Income Before Tax
-9
-6
-6
-5
-8
-11
-9
-9
-15
-12
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-9
-6
-6
-5
-8
-11
-9
-9
-15
-12
Net Profit Margin
70.09%
69.51%
55.54%
71.59%
74.76%
74.89%
79.85%
77.48%
76.06%
76.72%

RxSight Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
2
14
22
49
89
139
134
Gross Profit
-1
1
4
21
53
98
103
Operating Income
-46
-35
-52
-63
-50
-36
-48
EBITDA
130
32
-41
-57
-41
-23
-35
Interest Expense
0
0
3
4
3
0
0
Depreciation
3
4
3
4
4
3
3
Income Before Tax
126
27
-48
-66
-48
-27
-38
Income Tax Expense
0
0
0
0
0
0
0
Net Income
126
27
-48
-66
-48
-27
-38
Net Profit Margin
-81.17%
11.62%
19.99%
43.52%
60.36%
70.71%
76.60%

RxSight Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-6
-6
-5
-8
-11
-9
-9
-15
-12
Operating Cash Flow
-9
-4
0
-4
-8
-4
-1
-1
-10
-9
Investing Cash Flow
24
-115
-9
1
20
14
-9
-9
8
4
Financing Cash Flow
7
111
0
2
0
2
0
1
0
0
Change in Cash
22
-8
-7
0
11
12
-10
-9
-2
-4

RxSight Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
126
27
-48
-66
-48
-27
-38
Operating Cash Flow
-40
-35
-44
-58
-41
-16
-15
Investing Cash Flow
-5
15
-81
39
-22
-99
16
Financing Cash Flow
1
25
137
6
61
123
1
Change in Cash
-45
5
10
-12
-2
7
3

Global Institutional Holdings in RxSight

Check out the Institutions with significant holdings in RxSight.

Funds
Holdings
Jeff Osher
4.94%
Vanguard
4.87%
VANGUARD INDEX FUNDS
3.94%
iShares
3.84%
Xtrackers
3.70%
See all

RxSight News & Key Events

    Insights on RxSight

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 30.89M → 33.74M (in $), with an average increase of 8.4% per quarter

    • imgPOSITIVE IMPACT

      Profit Spike

      img

      Netprofit is up for the last 2 quarters, -15.88M → -12.09M (in $), with an average increase of 31.3% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 7 days, RXST stock has moved up by 3.5%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Edwards Lifesciences Corp has given 15.8% return, outperforming this stock by 60.8%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Medtronic plc has given 25.5% return, outperforming this stock by 106.5%

    About RxSight

    As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
    OrganisationRxSight
    Headquarters100 Columbia, Aliso Viejo, CA, 92656, US
    IndustryMedical - Devices
    CEOAziz Mottiwala

    Key Management of RxSight

    Name

    Title

    Dr. Ronald M. Kurtz M.D.

    Chief Medical Officer

    Mr. Jim Schindler

    Executive VP & General Counsel

    Mr. Patrick Cullen

    Executive VP of Quality & Infrastructure Operations

    Mr. Adam Dashe

    Executive Vice President of International

    Dr. Ilya Goldshleger Ph.D.

    Chief Operating Officer

    Mr. Eric J. Weinberg

    Chief Business Development Officer

    Mr. Aziz Mottiwala M.B.A.

    President, CEO & Director

    Mr. Mark Wilterding

    Chief Financial Officer

    Mr. Oliver Moravcevic

    Vice President of Investor Relations

    Ms. Maureen O'Connell

    Executive VP of Clinical & Regulatory Affairs

    FAQs

    What is RxSight share price today?

    RxSight share price today is $4.88 as on at the close of the market. RxSight share today touched a day high of $4.92 and a low of $4.66.

    What is the 52 week high and 52 week low for RxSight share?

    RxSight share touched a 52 week high of $13.22 on and a 52 week low of $4.40 on . RxSight stock price today i.e. is closed at $4.88,which is 63.09% down from its 52 week high and 10.91% up from its 52 week low.

    What is RxSight's market capitalisation today?

    RxSight market capitalisation is $0.00T as on .

    How to invest in RxSight Stock (RXST) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for RxSight on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy RxSight Stock (RXST) from India?

    Indian investors can start investing in RxSight (RXST) shares with as little as ₹94.93000030517578 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.30 in RxSight stock (as per the Rupee-Dollar exchange rate as on ). Based on RxSight share’s latest price of $4.88 as on October 21, 2026 at 1:29 am IST, you will get 2.0492 shares of RxSight. Learn more about fractional shares .

    What are the returns that RxSight has given to Indian investors in the last 5 years?

    RxSight stock has given -60.19% share price returns and 26.89% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?